FDA Approved: INOMAX — Supplemental Application (INO Therapeutics LLC)

View source ↗

Summary

The FDA approved a supplemental application for INOMAX (nitric oxide) from INO Therapeutics LLC, resulting in updated labeling for this inhaled therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Pulmonary Hypertension of the Newborn

Drugs mentioned

• INOmax (nitric oxide)

Snippet

SUPPL AP for INOMAX (NITRIC OXIDE)